At the 27th Milken Institute Global Conference, FasterCures curated public sessions centered around this year's theme, "Shaping a Shared Future." The emerging key health trends were prevention, AI, early cancer detection, and creating more equitable clinical trials. Read this issue brief for more health trends from Global Conference: https://lnkd.in/g6JpgZCv
FasterCures’ Post
More Relevant Posts
-
The landscape for Huntington's disease research is ever-shifting and changing. With new advances in technology for treatment and understanding, we're going to delve deeper into the landscape and key aspects such as imaging biomarkers and natural history studies in HD research to provide valuable insights into disease progression and treatment efficacy. Join Cristina Sampaio from CHDI Foundation and Marina Papoutsi from IXICO as they cover the following: · The current clinical trial landscape for Huntington’s Disease · The challenges and opportunities · The role of imaging and natural history data in HD clinical trials · Your chance to have your questions answered at the end of the webinar Date: Thursday, September 14th 2023 Time: 4pm BST / 11am EST Register here: https://lnkd.in/eZ4h_M6A If you have questions about the upcoming webinar that you want us to think about answering, let us know by dropping them in the comments or messaging us at hello@ixico.com If you can't make it to the webinar but want the recording, register anyway so we can send it to your inbox after the webinar has concluded. #huntingtonsdisease #hdresearch #huntingtonsdiseaseresearch #clinicalresearch #neuroimaging
To view or add a comment, sign in
-
Tomorrow, we're going to do a deep dive into the current Huntington's disease landscape, and the impact of imaging biomarkers and natural history studies have on treating this debilitating disease. Join us on Thursday, Sept 14th 2023 at 4 pm BST / 11am EST as Cristina Sampaio from CHDI Foundation and our very own Marina Papoutsi will go through the following: - The current clinical trial landscape for Huntington’s Disease - The challenges and opportunities - The role of imaging and natural history data in HD clinical trials - Answering your questions at the end of the webinar Register here https://lnkd.in/eZ4h_M6A Share this webinar with anyone that you think is going to benefit from this webinar and the knowledge that Cristina and Marina will be sharing to help you navigate your efforts in HD research. #huntingtonsdisease #huntingtonsdiseaseresearch #imagingbiomarkers #neuroimaging
To view or add a comment, sign in
-
Cancer and chronic health issues can affect anyone. But for too long, medicine has ignored queer and trans people's unique needs. At Summit 2023, speakers gathered to discuss how to improve the representation of our communities in research. Check out the panel for yourself: https://lnkd.in/gPi4CNAV
To view or add a comment, sign in
-
Are you looking for a unique and insightful summer read? Our summer issue of IMPACT, our digital magazine, delves into compelling stories showcasing our unwavering dedication to exceptional patient care, pioneering research and shaping the future of healthcare leadership. Highlights include: ✨ Science Over Stigma: Probing the physical causes of obesity ✨ The Sounds of Science: Giving voice to disease screening ✨ Bones’ Secret Cells: New connections to cancer and birth defects Dive into these fascinating articles: https://bit.ly/3XQGM4E
IMPACT Summer 2024
To view or add a comment, sign in
-
Identifying Alzheimer’s disease (AD) during the pre-clinical stage remains a challenge, but we’re finding hope in precision medicine to slow or even prevent the disease up to 20 years before symptoms appear. Watch to learn how #MyCompany is using digital, blood, and imaging biomarkers to help us identify the disease in its earliest stages and improve patient outcomes for those living with AD. If you’re curious about biomarkers in early intervention of disease, I encourage you to read my blog post – and let me know what you think about the future of AD research in the comments: https://bit.ly/44DiXNu #ENDALZ #AlzheimersDisease #MyCompany #AlzheimersDiseaseMonth
To view or add a comment, sign in
-
When it comes to heart health, there's very few that know more than, Stamford Professor, Michael V. McConnell, MD, MSEE. In this Expert Interview, he uncovers the links between cancer and heart health as well as how we could use AI to spot early signs of a poorly heart. Tune in today: https://lnkd.in/ewK8JN3E
To view or add a comment, sign in
-
Today, we had a conversation on Religion and health. Look out for the video, to learn about some of the issues within this topic, that will be discussed at the upcoming (June 7, 2024) Global Health Catalyst Summit, under the theme Cancer Moonshot 2.0.
To view or add a comment, sign in
-
As we honor the rich history and achievements of the African American community this #BlackHistoryMonth, it's crucial to shed light on the persistent health disparities that exist. Did you know that people of color face worse outcomes in bladder cancer? It's a stark reality we must confront. Join us in revisiting an eye-opening webinar from 2021, where Dr. Samuel Washington, MD and Dr. Heather Honoré Goltz. PhD, dive into the complex intersections of race, biology, and psychosocial factors impacting bladder cancer incidents and survival rates. Watch the enlightening discussion and gain insights into the healthcare inequities faced by communities of color. Let's take a moment to educate ourselves on the challenges that persist. 🔗 Click below to watch the webinar and access the accompanying transcript. Knowledge is power, and together we can work towards a healthier, more equitable future. https://lnkd.in/euGf2Avs
To view or add a comment, sign in
-
From breakthroughs in biomarkers to the resurgence of Alzheimer's disease clinical trials, our latest blog delves into the current landscape and future directions in AD research. Recommend the read! https://bit.ly/4efNsyT
Read Our Blog: The Role of Surrogate Biomarkers in in AD Therapeutics
To view or add a comment, sign in
-
From breakthroughs in biomarkers to the resurgence of Alzheimer's disease clinical trials, our latest blog delves into the current landscape and future directions in AD research. Recommend the read! https://bit.ly/4efNsyT
Read Our Blog: The Role of Surrogate Biomarkers in in AD Therapeutics
To view or add a comment, sign in
3,536 followers
More from this author
-
FasterCures Hosts Research Partnership Maturity Model Interactive Workshop for Network of Nonprofit Patient Foundation Leaders
FasterCures 1y -
FasterCures Hosts Research Partnership Maturity Model Interactive Workshop for Network of Nonprofit Patient Foundation Leaders
FasterCures 1y -
A Message from FasterCures Executive Director Esther Krofah
FasterCures 1y